Research to develop a safe, effective and widely available Covid-19 vaccine is advancing rapidly. But when it will happen is not clear. Much depends on how we govern the production and distribution of new drugs.
While the World Health Organisation's Covid-19 Technology Access Pool promises to foster accessibility, the actual availability of vaccines and treatments will also hinge on local manufacturing capacity, which in many countries has been eroded by de-industrialisation.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you